Literature DB >> 9864389

Assessment of genomic imbalances in malignant fibrous histiocytomas by comparative genomic hybridization.

R Hinze1, U Schagdarsurengin, H Taubert, A Meye, P Würl, H J Holzhausen, F W Rath, H Schmidt.   

Abstract

In order to investigate genomic imbalances, comparative genomic hybridization was applied to 20 malignant fibrous histiocytomas. Deletions were rare and found mainly in chromosomes 2q33-35, 4q32-qter, 8p, 9p21-pter, 12p and 19p, whereas, over-representations frequently affected chromosomes 3, 4q31, 5p, 6, 7, 14q22-ter, 18p, as well as, five distinct amplifications within the regions 12q12-15 and 15q24-qter. The total number of genetic imbalances per tumor was slightly increased in primary tumors when compared to relapses. No relationship was found between the patterns of gain and loss when compared to the histological subtype, tumor grading, the clinical outcome and the p53 mutation status.

Entities:  

Mesh:

Year:  1999        PMID: 9864389     DOI: 10.3892/ijmm.3.1.75

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  4 in total

1.  DNA copy number changes in human malignant fibrous histiocytomas by array comparative genomic hybridisation.

Authors:  Stine H Kresse; Hege O Ohnstad; Bodil Bjerkehagen; Ola Myklebost; Leonardo A Meza-Zepeda
Journal:  PLoS One       Date:  2010-11-09       Impact factor: 3.240

2.  Establishment of a new human pleomorphic malignant fibrous histiocytoma cell line, FU-MFH-2: molecular cytogenetic characterization by multicolor fluorescence in situ hybridization and comparative genomic hybridization.

Authors:  Jun Nishio; Hiroshi Iwasaki; Kazuki Nabeshima; Masako Ishiguro; Teruto Isayama; Masatoshi Naito
Journal:  J Exp Clin Cancer Res       Date:  2010-11-24

3.  Nonrandom chromosomal imbalances in esophageal squamous cell carcinoma cell lines: possible involvement of the ATF3 and CENPF genes in the 1q32 amplicon.

Authors:  A Pimkhaokham; Y Shimada; Y Fukuda; N Kurihara; I Imoto; Z Q Yang; M Imamura; Y Nakamura; T Amagasa; J Inazawa
Journal:  Jpn J Cancer Res       Date:  2000-11

4.  YES1 amplification confers trastuzumab-emtansine (T-DM1) resistance in HER2-positive cancer.

Authors:  Lei Wang; Quanren Wang; Piaopiao Xu; Li Fu; Yun Li; Haoyu Fu; Haitian Quan; Liguang Lou
Journal:  Br J Cancer       Date:  2020-06-23       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.